Stimcell Energetics (STME) Total Current Liabilities (2011 - 2019)
Stimcell Energetics' (STME) quarterly Total Current Liabilities came in at $1.9 million in Q1 2019, up 85.79% year-on-year from $1.0 million in Q1 2018, and up 21.42% quarter-over-quarter from $1.5 million in Q4 2018.
Stimcell Energetics (STME) Total Current Liabilities (2011 - 2019) Analysis & Trends
Stimcell Energetics' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $1.9 million for Q1 2019.
- On a quarterly basis, Total Current Liabilities rose 85.79% year-over-year to $1.9 million in Q1 2019; TTM through Feb 2019 was $1.9 million, a 85.79% increase from a year earlier, with the FY2018 full-year figure at $1.1 million, down 23.54% from the prior year.
- Total Current Liabilities improved to $1.9 million in Q1 2019 per STME's latest filing, from $1.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.9 million in Q1 2019 and bottomed at $981625.0 in Q4 2017.
- The 4-year median for Total Current Liabilities is $1.4 million (2017), against an average of $1.4 million.
- Across the five-year window, Total Current Liabilities fell 23.54% in 2018 and jumped 85.79% in 2019, its largest moves.
- Year by year, Total Current Liabilities stood at $1.7 million in 2016, then plunged by 41.62% to $981625.0 in 2017, then jumped by 56.09% to $1.5 million in 2018, then climbed by 21.42% to $1.9 million in 2019.
- Per Business Quant, the three latest STME Total Current Liabilities figures stand at $1.9 million (Q1 2019), $1.5 million (Q4 2018), and $1.4 million (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2019 | 1.86 Mn |
| Nov 30, 2018 | 1.53 Mn |
| Aug 31, 2018 | 1.37 Mn |
| May 31, 2018 | 1.12 Mn |
| Feb 28, 2018 | 1.00 Mn |
| Nov 30, 2017 | 981,625.00 |
| Aug 31, 2017 | 1.56 Mn |
| May 31, 2017 | 1.46 Mn |
| Feb 28, 2017 | 1.11 Mn |
| May 31, 2016 | 1.68 Mn |
| May 31, 2014 | 21,596.00 |
| May 31, 2013 | 12,847.00 |
| Feb 28, 2013 | 12,947.00 |
| Nov 30, 2012 | 12,947.00 |
| May 31, 2012 | 12,847.00 |
| Feb 29, 2012 | 16,956.00 |
| Nov 30, 2011 | 12,847.00 |
| Aug 31, 2011 | 6,965.00 |
| May 31, 2011 | 3,390.00 |